Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study

@article{Peisenetal23,
  title = {Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study},
  journal = {Diagnostics (Basel)},
  volume = {13},
  number = {20},
  month = oct,
  year = {2023},
  author = {Peisen, F. and Gerken, A. and Dahm, I. and Nikolaou, K. and Eigentler, T. and Amaral, T. and Moltz, J. H: and Othman, A. E. and Gatidis, S. and Dondi, F.},
  doi = {10.3390/diagnostics13203210},
  month_numeric = {10}
}